Literature DB >> 9621018

The effects of pharmacological and lentivirus-induced immune suppression on orbivirus pathogenesis: assessment of virus burden in blood monocytes and tissues by reverse transcription-in situ PCR.

S J Brodie1, W C Wilson, P M O'Hearn, D Muthui, K Diem, L D Pearson.   

Abstract

We investigated the effects of pharmacological and lentivirus-induced immunosuppression on bluetongue virus (BTV) pathogenesis as a mechanism for virus persistence and induction of clinical disease. Immunologically normal and immunosuppressed sheep were infected subcutaneously with BTV serotype 3 (BTV-3), a foreign isolate with unknown pathogenicity in North American livestock, and with North American serotype 11 (BTV-11). Erythrocyte-associated BTV RNA was detected earlier and at greater concentrations in sheep treated with immunosuppressive drugs. Similarly, viral RNA and infectious virus were detected in blood monocytes earlier and at higher frequency in immunosuppressed animals: as many as 1 in 970 monocytes revealed BTV RNA at peak viremia, compared to <1 in 10(5) monocytes from immunocompetent sheep. Animals infected with BTV-3 had a higher virus burden in monocytes and lesions of greater severity than those infected with BTV-11. BTV RNA was detected by in situ hybridization in vascular endothelial cells and cells of monocyte lineage, but only in tissues from immunocompromised animals, and was most abundant in animals infected with BTV-3. In contrast, reverse transcription-in situ PCR showed BTV RNA from both viral serotypes in high numbers of tissue leukocytes and vascular endothelial cells from both immunosuppressed and, to a lesser extent, immunocompetent animals. Collectively, these findings show that BTV infection is widely distributed during acute infection but replication is highly restricted in animals with normal immunity. These findings also suggest that in addition to virulence factors that define viral serotypes, immunosuppression could play a role in the natural history of orbivirus infection, allowing for higher virus burden, increased virus persistence, and greater potential for acquisition of virus by the arthropod vector.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621018      PMCID: PMC110219     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  Pathogenesis of bluetongue virus infection of cattle.

Authors:  S M Barratt-Boyes; N J MacLachlan
Journal:  J Am Vet Med Assoc       Date:  1995-05-01       Impact factor: 1.936

2.  Impaired cellular immune response in harbour seals (Phoca vitulina) feeding on environmentally contaminated herring.

Authors:  R L De Swart; P S Ross; H H Timmerman; H W Vos; P J Reijnders; J G Vos; A D Osterhaus
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

3.  Experimentally induced infection with bluetongue virus serotype 11 in cows.

Authors:  I M Parsonson; L H Thompson; T E Walton
Journal:  Am J Vet Res       Date:  1994-11       Impact factor: 1.156

4.  The pathogenesis of bluetongue virus infection of bovine blood cells in vitro: ultrastructural characterization.

Authors:  A W Brewer; N J MacLachlan
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Evolution of the L2 gene of strains of bluetongue virus serotype 10 isolated in California.

Authors:  C C de Mattos; C A de Mattos; B I Osburn; N J MacLachlan
Journal:  Virology       Date:  1994-05-15       Impact factor: 3.616

6.  Virological markers in cerebrospinal fluid are predictive of ovine lentivirus-associated subclinical encephalomyelitis.

Authors:  S J Brodie; H M Bickle; J C DeMartini
Journal:  Clin Immunol Immunopathol       Date:  1995-10

7.  Flow cytometric analysis of in vitro bluetongue virus infection of bovine blood mononuclear cells.

Authors:  S M Barratt-Boyes; P V Rossitto; J L Stott; N J MacLachlan
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891

8.  Dynamics of viral spread in bluetongue virus infected calves.

Authors:  S M Barratt-Boyes; N J MacLachlan
Journal:  Vet Microbiol       Date:  1994-06       Impact factor: 3.293

9.  Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues.

Authors:  S J Brodie; L D Pearson; M C Zink; H M Bickle; B C Anderson; K A Marcom; J C DeMartini
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

10.  Diagnostic analysis of the prolonged bluetongue virus RNA presence found in the blood of naturally infected cattle and experimentally infected sheep.

Authors:  J Katz; D Alstad; G Gustafson; J Evermann
Journal:  J Vet Diagn Invest       Date:  1994-04       Impact factor: 1.279

View more
  5 in total

1.  HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death.

Authors:  S J Brodie; B K Patterson; D A Lewinsohn; K Diem; D Spach; P D Greenberg; S R Riddell; L Corey
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Bluetongue virus targets conventional dendritic cells in skin lymph.

Authors:  Behzad Hemati; Vanessa Contreras; Céline Urien; Michel Bonneau; Haru-Hisa Takamatsu; Peter P C Mertens; Emmanuel Bréard; Corinne Sailleau; Stéphan Zientara; Isabelle Schwartz-Cornil
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

3.  Dendritic cell subtypes from lymph nodes and blood show contrasted gene expression programs upon Bluetongue virus infection.

Authors:  Suzana Ruscanu; Luc Jouneau; Céline Urien; Mickael Bourge; Jérôme Lecardonnel; Marco Moroldo; Benoit Loup; Marc Dalod; Jamila Elhmouzi-Younes; Claudia Bevilacqua; Jayne Hope; Damien Vitour; Stéphan Zientara; Gilles Meyer; Isabelle Schwartz-Cornil
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

4.  Involvement of the skin during bluetongue virus infection and replication in the ruminant host.

Authors:  Karin E Darpel; Paul Monaghan; Jennifer Simpson; Simon J Anthony; Eva Veronesi; Harriet W Brooks; Heather Elliott; Joe Brownlie; Haru-Hisa Takamatsu; Philip S Mellor; Peter Pc Mertens
Journal:  Vet Res       Date:  2012-04-30       Impact factor: 3.683

Review 5.  Potential of Using Capripoxvirus Vectored Vaccines Against Arboviruses in Sheep, Goats, and Cattle.

Authors:  Mahder Teffera; Shawn Babiuk
Journal:  Front Vet Sci       Date:  2019-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.